{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:14:32Z","timestamp":1787858072342,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1002\/jps.22395","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T18:03:22Z","timestamp":1290621802000},"page":"1702-1711","source":"Crossref","is-referenced-by-count":49,"title":["Encapsulation of Valproate-Loaded Hydrogel Nanoparticles in Intact Human Erythrocytes: A Novel Nano-cell Composite for Drug Delivery"],"prefix":"10.1016","volume":"100","author":[{"given":"Mehrdad","family":"Hamidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soliman","family":"Mohammadi-Samani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22395_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/713840329","article-title":"Carrier erythrocytes: An overview","volume":"10","author":"Hamidi","year":"2003","journal-title":"Drug Deliv"},{"key":"10.1002\/jps.22395_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J Control Rel"},{"issue":"1\u20132","key":"10.1002\/jps.22395_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2007.01.025","article-title":"Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery","volume":"338","author":"Hamidi","year":"2007","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.22395_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2007.04.001","article-title":"Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b","volume":"341","author":"Hamidi","year":"2007","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1002\/jps.22395_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10717540701203000","article-title":"Preparation and validation of carrier human erythrocytes loaded by bovine serum albumin as a model antigen\/protein","volume":"14","author":"Hamidi","year":"2007","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1002\/jps.22395_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425247.2.2.311","article-title":"Erythrocyte-based drug delivery","volume":"2","author":"Rossi","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1002\/jps.22395_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/107175401317245903","article-title":"in vitro characterization of human intact erythrocytes loaded by enalaprilat","volume":"8","author":"Hamidi","year":"2001","journal-title":"Drug Deliv"},{"key":"10.1002\/jps.22395_bb0040","series-title":"Preparation and in vitro characterization of carrier erythrocytes for long-circulating delivery of tramadol","author":"Foroozesh","year":"2007"},{"key":"10.1002\/jps.22395_bb0045","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3109\/03639049209040903","article-title":"Erythrocytes as carrier of metronidazole: In vitro characterization","volume":"18","author":"Talwar","year":"1992","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.22395_bb0050","first-page":"40","article-title":"Effect of glutaraldehyde treatment on rubomycin and hemoglobin leakage from murine erythrocytes loaded with rubomycin","volume":"2","author":"Ataullakhanov","year":"1993","journal-title":"Biotekhnologiia"},{"key":"10.1002\/jps.22395_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-4615-3030-5_37","article-title":"Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin","volume":"326","author":"Tonetti","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1002\/jps.22395_bb0060","series-title":"Erythrocyte engineering for Drug Delivery and Targeting","first-page":"99","article-title":"Erythrocytes as carriers of anthracycline antibiotics in vitro and in vivo","author":"Vitvitsky","year":"2002"},{"key":"10.1002\/jps.22395_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target specific nanoparticles: Theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1002\/jps.22395_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(01)00245-9","article-title":"Nanosized cationic hydrogels for drug delivery: Preparation, properties, and interactions with cells","volume":"54","author":"Vinogradov","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"10.1002\/jps.22395_bb0075","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22395_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389201033489748","article-title":"Application of chitin and chitosan derivatives in the pharmaceutical field","volume":"4","author":"Kato","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1002\/jps.22395_bb0085","first-page":"897","article-title":"Biocompatibility of chitosan by oral and intravenous administration","volume":"59","author":"Hirano","year":"1989","journal-title":"Polym Eng Sci"},{"key":"10.1002\/jps.22395_bb0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1461-5347(98)00059-5","article-title":"Pharmaceutical applications of chitosan","volume":"16","author":"Dodane","year":"1998","journal-title":"Pharm Sci Technol Today"},{"key":"10.1002\/jps.22395_bb0095","first-page":"5","article-title":"Chitosan, a drug carrier for the 21st century","volume":"10","author":"Paul","year":"2000","journal-title":"STP Pharm Sci"},{"key":"10.1002\/jps.22395_bb0100","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1002\/macp.1976.021771210","article-title":"Studies on chitin, 2. Effect of deacetylation on solubility","volume":"177","author":"Sannan","year":"1976","journal-title":"Makromol Chem"},{"key":"10.1002\/jps.22395_bb0105","first-page":"616","article-title":"Spray-drying for the preparation of chitosan microspheres","volume":"21","author":"Genta","year":"1994","journal-title":"Proc Int Symp Control Release Bioact Mater"},{"key":"10.1002\/jps.22395_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2007.04.009","article-title":"Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release","volume":"59","author":"Gan","year":"2007","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1002\/jps.22395_bb0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fernandez-Urrusuno","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22395_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22395_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.01.042","article-title":"Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate","volume":"295","author":"Wu","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22395_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(02)00548-3","article-title":"Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles","volume":"250","author":"Xu","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22395_bb0135","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/S0024-3205(99)00546-9","article-title":"in vitro and In vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by hypotonic dialysis procedure","volume":"65","author":"Sanz","year":"1999","journal-title":"Life Sci"},{"key":"10.1002\/jps.22395_bb0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1023\/A:1016049027661","article-title":"Erythrocytes as carriers for recombinant human erythropoietin","volume":"13","author":"Garin","year":"1996","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/jps.22395_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1097-0320(19961001)25:2<156::AID-CYTO4>3.0.CO;2-F","article-title":"Encapsulation of ribonucleic acid in human red blood cells for use as a reticulocyte quality control material for flow cytometric analysis","volume":"25","author":"Ebrahim","year":"1996","journal-title":"Cytometry"},{"issue":"3","key":"10.1002\/jps.22395_bb0150","first-page":"607","article-title":"Optimized recirculation survival of mouse carrier erythrocytes","volume":"17","author":"Chiarantini","year":"1991","journal-title":"Blood Cells"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491532147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491532147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:37:30Z","timestamp":1740721050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491532147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S002235491532147X"],"URL":"https:\/\/doi.org\/10.1002\/jps.22395","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}